Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

January 9, 2024

Primary Completion Date

April 2, 2024

Study Completion Date

July 3, 2024

Conditions
Atopic DermatitisEczema
Interventions
DIETARY_SUPPLEMENT

Placebo

"The placebo product containing mainly maltodextrin is presented in the same form as the active product, so that people handling the product cannot distinguish between them. The placebo is flavoured in order to have a fishy smell just like the active product.~2 capsules per day for 90 days of placebo."

DIETARY_SUPPLEMENT

ACT01

2 capsules per day (2 per dose) of 300mg (dose per capsule) for 90 days of study product.

DIETARY_SUPPLEMENT

ACT02

2 capsules per day (2 per dose) of 300mg (dose per capsule) for 90 days of study product.

Trial Locations (1)

08013

Eurofins, Barcelona

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Eurofins

INDUSTRY

lead

Abyss Ingredients

INDUSTRY

NCT06268847 - Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms | Biotech Hunter | Biotech Hunter